Affinity DataIC50: 300nMAssay Description:Reversal of P-gp mediated multidrug resistance in human HepG2/DOX cells assessed as doxorubicin IC50 at 10 uM measured within 48 hrs by MTT assay (Rv...More data for this Ligand-Target Pair
Affinity DataIC50: 1.20E+3nMAssay Description:Reversal of P-gp mediated multidrug resistance in human MCF7/ADM cells assessed as doxorubicin IC50 at 10 uM measured within 48 hrs by MTT assay (Rvb...More data for this Ligand-Target Pair
Affinity DataIC50: 1.30E+3nMAssay Description:Reversal of P-gp mediated multidrug resistance in human HepG2/DOX cells assessed as doxorubicin IC50 at 10 uM measured within 48 hrs by MTT assay (Rv...More data for this Ligand-Target Pair
Affinity DataIC50: 1.40E+3nMAssay Description:Reversal of P-gp mediated multidrug resistance in human HepG2/DOX cells assessed as doxorubicin IC50 at 5 uM measured within 48 hrs by MTT assay (Rvb...More data for this Ligand-Target Pair
Affinity DataIC50: 3.70E+3nMAssay Description:Reversal of P-gp mediated multidrug resistance in human MCF7/ADM cells assessed as doxorubicin IC50 at 10 uM measured within 48 hrs by MTT assay (Rvb...More data for this Ligand-Target Pair
Affinity DataIC50: 4.70E+3nMAssay Description:Reversal of P-gp mediated multidrug resistance in human HepG2/DOX cells assessed as doxorubicin IC50 at 5 uM measured within 48 hrs by MTT assay (Rvb...More data for this Ligand-Target Pair
Affinity DataIC50: 1.46E+4nMAssay Description:Reversal of P-gp mediated multidrug resistance in human MCF7/ADM cells assessed as doxorubicin IC50 at 5 uM measured within 48 hrs by MTT assay (Rvb ...More data for this Ligand-Target Pair
Affinity DataIC50: 1.78E+4nMAssay Description:Reversal of P-gp mediated multidrug resistance in human MCF7/ADM cells assessed as doxorubicin IC50 at 5 uM measured within 48 hrs by MTT assay (Rvb ...More data for this Ligand-Target Pair